Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor
Kyoji Yamaguchi(Daiichi-Sankyo (Japan)), Kanji Higashio(Megmilk Snow Brand (Japan)), Toshio Suda(Chinese Academy of Sciences), F Kobayashi(Megmilk Snow Brand (Japan)), Tomonori Morinaga(SHOWA Medical University), Masahiko Kinosaki(Megmilk Snow Brand (Japan)), Masaaki Goto(SHOWA Medical University)
Cited by 203
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771